Across TCGA pan-cancer cohorts, RNU6-785P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-785P data layer.
The strongest signal is observed in brain lower grade glioma (LGG), where higher RNU6-785P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-785P expression acts as an unfavorable survival marker.
LGG and READ are the cancer types where RNU6-785P RNA most reproducibly stratifies survival.